Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Indo Acidatama TbkISX:SRSN +1.03%85 3-Year EBITDA Growth Rate is 26.20% as of Jun. 2026, which is 870% above its 10-year median of 2.70. GuruFocus rates ISX:SRSN with a GF Score™ of 85/100 and a GF Value™ of Rp60.38 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,414 Chemicals companies, PT Indo Acidatama Tbk ranks better than 85.5% on this metric.
During the past 12 months, PT Indo Acidatama Tbk's average EBITDA Per Share Growth Rate was 189.40% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 26.20% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 5.00% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 11.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of PT Indo Acidatama Tbk was 50.20% per year. The lowest was -19.30% per year. And the median was 2.70% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
PT Indo Acidatama Tbk 3-Year EBITDA Growth Rate Related Terms
ISX:SRSN vs DOW: 3-Year EBITDA Growth Rate Comparison
For the Chemicals subindustry, PT Indo Acidatama Tbk's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Indo Acidatama Tbk 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, PT Indo Acidatama Tbk's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where PT Indo Acidatama Tbk's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 26.20% mean?
PT Indo Acidatama Tbk (ISX:SRSN) has a 3-Year EBITDA Growth Rate of 26.20% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for PT Indo Acidatama Tbk and its competitors. This is 870% above median its historical median of 2.70. According to the industry distribution chart, PT Indo Acidatama Tbk ranks #205 out of 1414 companies in the Chemicals industry, placing it in the top 14.5%.
Is PT Indo Acidatama Tbk's 3-Year EBITDA Growth Rate too high?
PT Indo Acidatama Tbk's current 3-Year EBITDA Growth Rate of 26.20% is 870% above median its 10-year median of 2.70. The Chemicals industry median 3-Year EBITDA Growth Rate is 0.70. PT Indo Acidatama Tbk's value of 26.20% is 3642.9% above this industry median. Based on the distribution chart, PT Indo Acidatama Tbk ranks #205 out of 1414 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, PT Indo Acidatama Tbk has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Indo Acidatama Tbk's 3-Year EBITDA Growth Rate compare to DOW?
According to the Chemicals industry distribution chart, PT Indo Acidatama Tbk ranks #205 out of 1414 companies for 3-Year EBITDA Growth Rate. This places PT Indo Acidatama Tbk in the top 15% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 0.70. PT Indo Acidatama Tbk's value of 26.20% is 3642.9% above this benchmark. While the company's 10-year median is 2.70 vs. the industry median of 0.70, PT Indo Acidatama Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.70, based on 1,414 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Indo Acidatama Tbk's current 3-Year EBITDA Growth Rate of 26.20% is 3642.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for PT Indo Acidatama Tbk and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Indo Acidatama Tbk's current 3-Year EBITDA Growth Rate is 26.20%, which is 870% above median its own 10-year median of 2.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Indo Acidatama Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Indo Acidatama Tbk (ISX:SRSN) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp60.38, compared to a current price of Rp98.00 — trading 62.3% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 26.20%, which is 870% above median its 10-year median of 2.70 and 3642.9% above the Chemicals industry median of 0.70. PT Indo Acidatama Tbk's overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For PT Indo Acidatama Tbk (ISX:SRSN), the current 3-Year EBITDA Growth Rate is 26.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Indo Acidatama Tbk (ISX:SRSN) Overvalued in 2026?
Based on GuruFocus' analysis, PT Indo Acidatama Tbk stock appears to be overvalued.
The current stock price of Rp98.00 is trading 62.3% above its estimated GF Value™ of Rp60.38.
GuruFocus considers PT Indo Acidatama Tbk to be Significantly Overvalued.
Key valuation signals for ISX:SRSN:
3-Year EBITDA Growth Rate: 26.20% (870% above median its 10-year median of 2.70)
GF Value™: Rp60.38 vs. price of Rp98.00 (62.3% above fair value)
Industry Position: 3642.9% above the Chemicals median (#205 of 1414)
No single metric tells the full story. See the ISX:SRSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Indo Acidatama Tbk is an Indonesian-based company engaged in manufacturing ethanol. The company produces acetic acid, ethyl acetate, bio-organic fertilizers, methylated spirit, and carbonic acid gas. It operates business activity in segments such as Ethanol, Acetic Acid, and Others. The fertilizers of the company are marketed under the brand names Pomi, Randex, Beka, and Alfinas. The company earns the majority of its revenue from the Ethanol segment.
85GF Score
Get the complete analysis for ISX:SRSN
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SRSN has been successfully added to your 
